UK’s Future Health Works acquired by US MSK player

Zina Fragkiadaki
June 7, 2022
M&A
From left: Tom Harte, co-founder of msk.ai and former surgical trainee and Axel Sylvan, doctor and co-founder

London-based Future Health Works (FHW), a healthtech firm and owner of patient engagement platforms myrecovery and msk.ai, has been acquired by Healthcare Outcomes Performance Company (HOPCo), a US player in musculoskeletal (MSK) physician practice management, outcomes management and value-based care solutions.

The terms of the deal have not been disclosed.

The transaction will enable FHW to develop further solutions to help support the elective care on NHS waiting lists, whilst leveraging HOPCo’s infrastructure to expand across the USA, the company said.

Over the next 12 months, FHW plans to “significantly” grow its London-based team, investing in data science, computer vision and engineering.

FHW’s patient engagement platforms supports patients, healthcare professionals, hospitals, and government organisations to deliver surgical care, manage waiting lists, optimise care pathways and measure outcomes. FHW started in orthopaedic surgery, and now supports the full spectrum of elective care. The platforms have been deployed in three continents and eight languages, supporting a wide range of public and private health care systems, as well as Fortune 500 companies.

HOPCo is currently partnered with health systems and physicians in more than 30 states and continues to partner with healthcare systems across the US in advanced value-based care programmes, including the country’s first state-wide MSK-focused population health programme in Arizona.  FHW’s technology will bolster HOPCo’s already robust outcomes management platform, claims analytics, clinical datasets, and IT tools.

The deal was facilitated and managed by MedWorld Advisors, a medtech/ healthcare specialised M&A advisory firm based in the US.

Subscriber content

To get unlimited access subscribe today

Subscribe

Already a subscriber? Login